Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. ASSET PURCHASE AND ROYALTY AGREEMENTAsset Purchase and Royalty Agreement • November 22nd, 2011 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AND ROYALTY AGREEMENT (this “Agreement”), is hereby entered into as of the 15th day of November, 2011 (the “Effective Date”) by and between Mylan Inc., a Pennsylvania corporation located at 1500 Corporate Drive, Canonsburg, Pennsylvania 15317 (“Mylan”) and Cumberland Pharmaceuticals Inc., a corporation organized under the laws of the State of Tennessee with a place of business at 2525 West End Avenue, Suite 950, Nashville, Tennessee, USA 37203 (hereinafter referred to as “Cumberland”). Mylan and Cumberland may each be referred to herein individually as a “Party” and collectively as the “Parties.”
